Related Experiment Video
Updated: Jun 19, 2026

13:55
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Turning neglected tropical diseases into forgotten maladies
Philip Musgrove1, Peter J Hotez
1Health Affairs, USA. pmusgrove@projecthope.org
Health Affairs (Project Hope)
|November 6, 2009
Summary
Neglected tropical diseases (NTDs) cause significant disability and economic loss, particularly in impoverished regions. Integrated mass drug administration and non-drug interventions offer cost-effective strategies for control and potential elimination within a decade.
Area of Science:
- Public Health
- Infectious Diseases
- Global Health
Background:
- Neglected tropical diseases (NTDs) disproportionately affect impoverished populations, causing substantial chronic disability.
- The full health, educational, and economic impact of NTDs, including their interaction with other major diseases like HIV/AIDS and malaria, is increasingly recognized.
- Despite their burden, NTDs have historically received less attention compared to diseases with higher mortality rates.
Purpose of the Study:
- To highlight the significant burden of neglected tropical diseases (NTDs) and advocate for increased attention and resources.
- To underscore the potential for controlling and eliminating several NTDs within a decade.
- To identify research needs for advancing NTD control and elimination strategies.
Main Methods:
- Review of existing data on the health, educational, and economic impact of NTDs.
- Analysis of the effectiveness of integrated mass drug administration programs.
- Assessment of the role of non-drug interventions in NTD control.
- Examination of disease interactions, such as NTDs with HIV/AIDS and malaria.
Main Results:
- NTDs impose a vast toll, contributing to severe chronic disabilities and hindering socioeconomic development in affected regions.
- Integrated, cost-effective mass drug administration programs, combined with non-drug interventions, show promise for NTD control and elimination.
- Several NTDs could potentially be controlled or eliminated within ten years through these integrated strategies.
Conclusions:
- Increased understanding of the NTD burden is driving a shift in their recognition and management.
- Integrated public health interventions, particularly mass drug administration, are highly effective and cost-efficient for tackling NTDs.
- Continued research is crucial to develop new control measures and achieve elimination for a wider range of NTDs.
Related Concept Videos
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
